Dinesh C Patel insider trades: Q Therapeutics stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Dinesh reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 7, 2014 | [NONE] | ↑ Buy | 50,000 | $1.00 | $50K | Direct | Mar 13, 2014 (6d) |
| May 25, 2005 | PRTX.OB | ↑ Buy | 1,076,923 | $1.95 | $2.1M | See note | Jun 8, 2005 (14d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Dinesh C Patel's insider trades
Dinesh C Patel is a director at Q Therapeutics. Since May 25, 2005, Dinesh has reported 2 open-market purchases worth $2.1M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.